| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed8b5c72be18a88c9a5a58cd2aec7698
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_955deaec776415c904d92144c286ec46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4483694d3dc2df997540aff58515b60 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-163 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413645d3b08b233dad87d7caa2799371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13418b89be7dc7f9c07904c748e2a64b |
| publicationDate |
2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014210082-A2 |
| titleOfInvention |
Camptothecin derivatives as anti-hiv agents and methods of identifying agents that disrupt vif self-association |
| abstract |
The present invention relates to the use of camptothecin derivatives as anti HIV agents that disrupt self-association of the viral infectivity factor (Vif) found in HIV and other retroviruses. The present invention also relates to methods of identifying agents that disrupt Vif self-association and methods of using these agents, including methods of treating or preventing HIV infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105907720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105907720-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588902-B2 |
| priorityDate |
2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |